PATENT CLAIM ANALYSIS

Application Number: 15990734
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "007400"]

Abstract:
There is provided protein biomarkers and methods for their use in diagnosing and treating Inflammatory Bowel Disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD) as well as methods for assessing the severity of the diseases.

Claim (Index 5):
A method of detecting Crohn's disease or ulcerative colitis and differentiating Crohn's disease from ulcerative colitis in a subject comprising:\n providing a sample obtained from the gut of a subject; detecting in said sample a level of each of the following markers: Trifunctional enzyme (mitochondrial), Sec61, SND1, LAP3, Leukotriene A4 hydrolase, MT2, Tricarboxylate transport (mitochondrial), HNRPH3, Sero-transferrin, delta(3,5)-delta(2,4)-dienoyl-CoA isomerase (mitochondrial; ECH1), Transferrin Receptor Protein 1 and Beta-2-microglobulin in a lower digestive tract sample from the human subject.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15477508', '14648207', '14743909', '14900867', '14675081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5445974102209803
- 35 USC 102 Novelty (BERT): 0.6113043534896069
- Combined Prediction Score: 0.551268104547843
- Mean Citation Score: 351.23441
- Max Citation Score: 634.816
- Similarity Product: 455.9562366256714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test